Institutional experience with extracorporeal membrane oxygenation in lung transplantation

Aigner, Clemens; Wisser, Wilfried; Taghavi, Shahrokh; Lang, György; Jaksch, Peter; Czyzewski, Damian; Klepetko, Walter
March 2007
European Journal of Cardio-Thoracic Surgery;Mar2007, Vol. 31 Issue 3, p468
Academic Journal
Abstract: Background: Extracorporeal membrane oxygenation (ECMO) is currently accepted in lung transplantation either to bridge patients to transplantation or to treat postoperatively arising severe primary graft failure. Based on promising initial experiences we have since 2001 implemented ECMO as the standard of intraoperative extracorporeal support in lung transplantation (LuTX) patients with haemodynamic or respiratory instability with the potential to prolong ECMO support into the perioperative period. The aim of this paper is to summarise our total experience with the use of ECMO in LuTX. Methods: We retrospectively reviewed all 306 patients undergoing primary lung transplantation from 1/2001 to 1/2006 with regard to the different forms of ECMO use. Results of all patients requiring ECMO were compared to those without ECMO during the observation period. Results: ECMO was used in 147 patients in total. Two patients were bridged to transplantation. A total of 130 patients received intraoperative ECMO support. In 51 of these patients ECMO was prolonged into the perioperative period. Five of these patients required ECMO support again in the postoperative period due to graft dysfunction. Contrary cardiopulmonary bypass was used in 27 patients mainly with concomitant cardiac defects. Eleven of these patients needed therapeutic ECMO in the further course. A total of 149 patients without relevant risk factors were transplanted without any intraoperative extracorporeal support. Six of these patients required ECMO support in the postoperative period for treatment of primary graft dysfunction. Overall 3-month, 1-year and 3-year survival rates were 88.6%, 82.1% and 74.63%. The mentioned survival rates were 85.4%, 74.2% and 67.6% in the intraoperative±prolonged ECMO group; 93.5%, 91.9% and 86.5% in the no support group and 74.0%, 65.9% and 57.7% in the CPB group. Conclusion: ECMO is a valuable tool in lung transplantation providing the potential to bridge patients to transplantation, to replace CPB with at least equal results and to overcome severe postoperative complications. Favourable survival rates can be achieved despite the fact that ECMO is used in the more complex patient population undergoing lung transplantation as well as to overcome already established severe complications.


Related Articles

  • Extracorporeal membrane oxygenation, an anesthesiologist's perspective: Physiology and principles. Part 1. Chauhan, Sandeep; Subin, S. // Annals of Cardiac Anaesthesia;Sep2011, Vol. 14 Issue 3, p218 

    Extracorporeal membrane oxygenation (ECMO) is an adaptation of conventional cardiopulmonary bypass techniques to provide cardiopulmonary support. ECMO provides physiologic cardiopulmonary support to aid reversible aspects of the disease process and to allow recovery. ECMO does not provide...

  • Cardiac ECMO for biventricular hearts after paediatric open heart surgery. Chaturvedi, R. R.; Macrae, D.; Brown, K. L.; Schindler, M.; Smith, E. C.; Davis, K. B.; Cohen, G.; Tsang, V.; Elliott, M.; de Leval, M.; Gallivan, S.; Goldman, A. P. // Heart;May2004, Vol. 90 Issue 5, p545 

    Objective: To delineate predictors of hospital survival in a large series of children with biventricular physiology supported with extracorporeal membrane oxygenation (ECMO) after open heart surgery.Results: 81 children were placed on ECMO after open heart surgery. 58%...

  • Interleukin-6 may predict survival in extracorporeal membrane oxygenation treatment. Risnes, I.; Wagner, K.; Ueland, T.; Mollnes, T. E.; Aukrust, P.; Svennevig, J. L. // Perfusion;May2008, Vol. 23 Issue 3, p173 

    The cytokine network and its association with complement activation during cardiac surgery with cardiopulmonary bypass (CPB) is complex. Extracorporeal membrane oxygenation (ECMO) differs from CPB in duration of days to weeks rather than hours. However, few studies have analyzed the levels of...

  • Two cases of bilateral lung transplantation combined with intracardiac repair and pulmonary artery replacement: perioperative managements based on the left ventricular function. Toyama, Hiroaki; Saitoh, Kazutomo; Takei, Yusuke; Ejima, Yutaka; Kurosawa, Shin; Yamauchi, Masanori // Journal of Anesthesia;Dec2015, Vol. 29 Issue 6, p957 

    We report on two patients who underwent bilateral lung transplantation (BLTx) combined with cardiac surgery. Patient 1 was a female whose pulmonary hypertension resulted from a congenital atrial septal defect (ASD) and idiopathic pulmonary arterial hypertension. She had a very small left...

  • Reply to Eberlein et al. Inci, Ilhan; Weder, Walter // European Journal of Cardio-Thoracic Surgery;Aug2013, Vol. 44 Issue 2, p395 

    A letter to the editor is presented in response to the article "Bilateral lobar lung transplantation and size mismatch by pTLC-ratio," by Eberlein M., Bolukbas S., and Reed R. M. in the 2013 issue.

  • High risk of intraoperative awareness during cardiopulmonary bypass with isoflurane administration via diffusion membrane oxygenators. Philipp, A; Wiesenack, C; Behr, R; Schmid, FX; Birnbaum, DE // Perfusion;May2002, Vol. 17 Issue 3, p175 

    In cardiac surgery with the aid of extracorporeal circulation (ECC), inhalation anaesthetics can be administered via the oxygenator. Until the recent advent of a new type of diffusion membrane oxygenator, we routinely added the inhalation agent, isoflurane, to the gas flow of a microporous...

  • Editorial. Punjabi, Prakash P. // Perfusion;Jan2009, Vol. 24 Issue 1, p5 

    The article discusses various reports published within the issue including one on the successful use of hand-held extracorporeal membrane oxygenation and its long-term use, one on bivalirudin as an anticoagulant for cardiac surgery and another propofol requirement and comparison of hypo- and...

  • Use of extracorporeal membrane oxygenation in Croatian lung transplantation programme. Our initial experience. Pavlisa, G.; Puretic, H.; Zuljevic, E.; Jakopovic, M.; Redzepi, G.; Jankovic, M.; Ivancan, V.; Biocina, B.; Samarzija, M. // Journal of Cardiothoracic Surgery;2013, Vol. 8 Issue Suppl 1, p1 

    An abstract of the article "Use of extracorporeal membrane oxygenation in Croatian lung transplantation programme. Our initial experience" by G. Pavlisa and colleagues is presented.

  • Creative Thinking Keeps Cystic Fibrosis Patient on His Feet.  // AARC Times;Sep2013, Vol. 37 Issue 9, p156 

    The article reports that clinicians from the Universityif Alabama in Birmingham deliberated on ways on how a cystic fibrosis patient, who is in need of extracorporeal membrane oxygenation, can remain healthy while awaiting a transplant.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics